---
type: "NewsArticle"
title: "Small GeNeurofil pilot reports cognitive and biomarker changes in MCI"
description: "In a six-month pilot with 54 people with mild-to-moderate cognitive impairment, GeNeurofil was associated with improved test scores and lower plasma markers; the authors call for larger confirmatory trials."
resource: "https://nootropikler.com/news/geneurofil-mci-pilot-trial"
tags: ["supplements", "cognition", "research"]
timestamp: 2026-10-05T01:04:23Z
language: "en"
---

# Small GeNeurofil pilot reports cognitive and biomarker changes in MCI

In a six-month pilot with 54 people with mild-to-moderate cognitive impairment, GeNeurofil was associated with improved test scores and lower plasma markers; the authors call for larger confirmatory trials.

Author: Nootropik News Editorial Team
Published: 2026-10-05T01:04:23Z
Update: 2026-10-05T01:04:23Z
News/source date: 2026-07-28
Production: AI-assisted sourced summary and translation; no independent medical expert review is claimed.

## Study design

A randomized, double-blind pilot assigned 54 people with cognitive impairment described as mild-to-moderate MCI to GeNeurofil or placebo for six months while they continued usual medications. The supplement was given as 0.7 mL three times daily; researchers assessed MMSE, Clinical Dementia Rating, mood and plasma NfL and phosphorylated tau.

## Findings

The authors reported six-month differences favoring GeNeurofil on CDR and MMSE, and lower plasma NfL and p-tau than placebo. Zung depression scores changed over time, but showed no treatment or treatment-by-time effect.

## Limits and disclosures

The sample was small, the study was retrospectively registered, and the trial was industry funded. Results are preliminary and do not establish clinical efficacy. The authors explicitly say larger trials are needed to confirm the findings.

## Sources

- [The impact of GeNeurofil™ nutraceutical supplementation on psychometric assessment and biomarkers of neurodegeneration in cognitive impaired patients: a pilot study](https://doi.org/10.1038/s41430-026-01791-6) — 2026-07-28
